Clinical Trials Browser

Phase 4 × Breast Neoplasms × eribulin × Clear all

NCT02864030 2021-03-04

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Phase 4 Completed

Breast Neoplasms, Neurotoxicity Syndromes, Drug-Related Side Effects and Adverse Reactions

NCT03583944 2019-11-27

A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer

Phase 4 Completed

Breast Neoplasms

NCT01961544 2016-10-07

ESKIMO

Phase 4 Completed

101 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis